The novel PR3-ANCA ELISA showed positive PR3-ANCA levels in 74 (24.0%) of 309 patients with PSC using the cut-off of 15 U/mL (Figure 1). This evidence concerns the gene PRTN3 and pancreatic serous cystadenoma.